Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Mindray Reports Higher Q2; Reduces 2010 Guidance

publication date: Aug 10, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
In a mixed Q2 financial report, Mindray Medical, a major China medical device company, reported higher numbers for the period, though revenues were below analysts’ predictions. The company blamed the miss on a decline in its Q2 China revenues, largely because of a shortfall in its revenues from government tenders. International sales, on the other hand, remained robust, rising 27%. More details...

Stock Symbol: (NYSE: MR)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...